Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 36 results for "ranjit kapadia"

Sanofi India: Relief a few quarters away
Business Standard India

Ranjit Kapadia bullish on Lupin, positive on Sanofi India

Ranjit Kapadia, Senior Vice President at Centrum Broking is bullish on Lupin and has a positive view on Sanofi India. Money Control, 4 weeks ago
Sanofi India: Relief a few quarters away Business Standard India, 1 month ago
Rediff.com

Pharma sector to gain from NPPA's withdrawal order: Centrum

According to Ranjit Kapadia, the sector will see a relief of around Rs 640 crore with Sanofi India being the biggest benefactor and saving almost Rs 140 crore post the withdrawal order.
 Money Control4 weeks ago Here's why pharma sector will continue outperforming  Moneycontrol.com1 week ago Pharma stocks could rise another 15-20%  Rediff.com2 months ago

Cadila recalls chest pain and hypertension tablets in US

Ahmedabad-based Cadila Healthcare's US division has voluntarily initiated recall of 5,400 bottles of atenolol tablets in the United States for failing to meet certain specifications. The drug is used to treat chest pain and hypertension. It is ...
 DNA India5 days ago CADILA HEALTHCARE : recalls chest pain, hypertension tablets in US  4 Traders2 days ago

Pharma companies may post healthy numbers on strong global business, rupee fall

Lupin, Cadila Healthcare, Torrent Pharma expected to post strong growth, but muted performance seen from Sun Pharma and Dr Reddy's RNA Research & Archives The pharmaceutical sector is likely to post strong earnings growth in the September ...
 DNA India3 days ago Sun Pharmaceutical Industries, Dr Reddy's face US action on price hikes up to 8,000%  DNA India2 weeks ago Sun, Reddy's face US action on price spikes [DNA : Daily News & Analysis (India)]  Pharmacy Choice1 week ago Pharma companies shrug off price control, grow domestic business  DNA India2 months ago
Business Standard India

Bulk drug makers eye 20% growth this year, bet on niche products

price control might have affected the revenues of formulation makers in the country, bulk drug makers, however, have a reason to cheer, as the industry expects 15-20 per cent growth during the fiscal. Most major active pharmaceutical ingredient ...
 Business Standard India4 days ago

CJI Lodha: Those talking of corruption in the judiciary are themselves involved in corruption

On September 19, Justice Rajendra Mal Lodha is relaxing on a settee in his Krishna Menon Marg bungalow. It's exactly a week before the five-month term of the 41st Chief Justice of India (CJI) draws to a close on September 27. His manner is more ...
 India Today3 weeks ago

Sun Pharma offsets BSE Healthcare losses; stock rallies 6%

MUMBAI: Shares of pharmaceutical major Sun Pharmaceuticals bounced back in weak trade and surged over 6 per cent as Credit Suisse report eased concerns of import alert at its Halol plant. According to the report, the company has received Form 483 ...
 Economic Times3 weeks ago Sun Pharmaceutical : in skin ailment drug deal with Merck  4 Traders1 month ago MERCK KGAA : Lupin expands portfolio with Merck deal  4 Traders1 month ago Sun Pharma to acquire skin ailment drug rights from Merck  DNA India1 month ago

Drug price decontrol will hit cardiac, diabetic patients hard

The National Pharmaceutical Pricing Authority (NPPA) on Monday announced the withdrawal of an internal guideline to fix prices of 108 non-scheduled formulations. Though the decision is disappointing for consumers, mainly cardiac and diabetes ...
 DNA India4 weeks ago IPCA Laboratories : Pharma cos may be hit by new price controls  4 Traders1 month ago Fresh drug price control rule may hit Indian pharmaceutical companies  DNA India1 month ago

2G Case: Justice Dattu seeks advice; KK Venugopal refuses citing conflict of interest, JethmalaniNew

The hearing in the 2G case in the Supreme Court took an interesting turn yesterday. All set to take over as the next Chief Justice of India (CJI), Justice Dattu initially sought Senior Advocate KK Venugopal's advice on whether the affidavit ...
 Bar & Bench1 month ago
DNA India

Sun tanks 6% as Halol unit comes under cloud

Shares of Sun Pharmaceutical Industries dropped over 4% on Thursday on unconfirmed reports that the US Food and Drug Administration (FDA) made a surprise inspection at its manufacturing facility at Halol in Gujarat. The scrip opened at Rs 853 on ...
 DNA India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less